Compare ADMA Biologics Inc (ADMA) vs Twilio Inc (TWLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Twilio Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Twilio Inc trades at $254.16 (market cap $39.31B). The key difference: Twilio Inc is far larger — about 17.7× ADMA Biologics Inc's market cap, and Twilio Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | TWLO | |
|---|---|---|
Market Cap | $2.22B | $39.31B |
Sector | Health | Technology |
52-Week High | $20.38 | $255.95 |
52-Week Low | $7.60 | $95.23 |
Enterprise Value | $2.29B | $37.72B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Twilio Inc
Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
Read more on TWLO →
